- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03972761
Evaluation of Brain Plasticity in Premature Infants at School Age After Cognitive Remediation (EPIREM)
Evaluation of Brain Plasticity in Premature Infants at School Age After Cognitive
Infantile brain plasticity is still a poorly known phenomenon. However, neuropsychological disorders and behavioral deficits are common disorders that can have serious consequences for school enrollment, family and social adjustment, as well as repercussions on future adult lives.
In addition, generally very premature infants (TGP) have identifiable executive function disorders (EF), particularly those involving attentional processes such as working memory (WM).
The main objective of the study is to evaluate the effects of cognitive remediation (CR) strategies on the brain plasticity of the cortical areas involved in the management of WM in school-aged TGP children (8 years).
The secondary objective of the study is to evaluate the action of CR on the development of cortical areas concerned
It is a monocentric, prospective and comparative study of the exposed type (to cognitive remediation) - unexposed. Recruitment and data collection are carried out prospectively, in connection with the original study (EPIREMED). Included patients will be explored by Magnetic Resonance Imaging (MRI) 3 resting state Tesla.
The main hypothesis is that CR strategies have a beneficial effect on the cognitive processing of visual-spatial executive functions, but also on the cortical areas involved in brain plasticity in general (indirect benefits); not to mention the psychological benefits ad hoc to such studies (self-esteem, increased concentration, new stress management strategies put in place).
The ultimate objective of this study is to better understand the mechanisms of cerebral plasticity concerning higher executive functions. Moreover, this study should make it possible to confirm the improvement of the overall fate of the child by better understanding the neuropsychological and anatomical origins of his disorders. Interventions taking into account the environment of the very premature baby are necessary because it is closely linked to the developmental future.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Barthélémy TOSELLO, PH
- Phone Number: +33 491968300
- Email: barthelemy.tosello@ap-hm.fr
Study Locations
-
-
-
Marseille, France, 13354
- Assistance Publique Hopitaux de Marseille
-
Contact:
- Barthélémy TOSELLO, PH
- Phone Number: +33 491968300
- Email: barthelemy.tosello@ap-hm.fr
-
Principal Investigator:
- Barthélémy TOSELLO, PH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children born between 24 and 34 weeks of amenorrhea and living in the Provence region
- Possessing an intelligence quotient (IQ) greater than 70
Exclusion Criteria:
- Child not understanding French
- Child who did not have all the interventions in the EPIREMED study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Group exposed to cognitive remediation
Computerized cognitive remediation program.
Program performed during inclusion in the EPIREMED patient study (Clinical trial number NCT02757794)
|
Functional neuroimaging objectifies the activation of specific areas of the brain
|
Placebo Comparator: Group not exposed to cognitive remediation
Standard remediation performed during inclusion in the EPIREMED patient study (Clinical trial number NCT02757794)
|
Functional neuroimaging objectifies the activation of specific areas of the brain
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Activation of cortical areas
Time Frame: 24 months
|
Hyper activation on the Magnetic Resonance Imaging (MRI) associated with working memory
|
24 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019-07
- 2019-A00829-48 (Other Identifier: ID RCB)
- RCAPHM19_0023 (Other Identifier: Secondary AP-HM number)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature Childbirth
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
AdventHealthDraegerActive, not recruitingPreterm Birth | Maternal Depressive Disorder Complicating Childbirth | Maternal Anxiety Disorder Complicating ChildbirthUnited States
-
Viveve Inc.CompletedVaginal Laxity Following Childbirth | Sexual Function Following ChildbirthCanada, Italy, Japan, Spain
-
Necmettin Erbakan UniversityCompletedPregnancy | Fear of Childbirth | Postpartum | Childbirth | Psychosocial HealthTurkey
-
University Hospital, CaenCompleted
-
Hacettepe UniversityCompletedFear of Childbirth | Mode of Delivery | Motivational Interview | Childbirth Self-efficacyTurkey
-
Tel Aviv UniversityHana BorrerCompleted
-
Woman's Health University Hospital, EgyptUnknown
Clinical Trials on Magnetic Resonance Imaging (MRI) 3 tesla
-
University of CincinnatiActive, not recruitingProstate CancerUnited States
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingProstate CarcinomaUnited States
-
University of MiamiRecruitingGlioma | Brain Tumor | Malignant Glioma | Primary Brain Tumor | Malignant Primary Brain TumorUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingMetastatic Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Malignant Neoplasm in the BrainUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingGlioma | Metastatic Malignant Solid Neoplasm | Central Nervous System Neoplasm | Metastatic Malignant Neoplasm in the Central Nervous SystemUnited States
-
Oslo University HospitalCompletedSurgery | Transposition of Great VesselsNorway
-
OHSU Knight Cancer InstituteCompleted
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedPrecancerous Condition | Adrenocortical Carcinoma | Localized Resectable NeuroblastomaUnited States, Canada, Australia